[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@BioCentury BioCentury
BioCentury posts on X about novartis, $googl the most. They currently have XXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXXX +3,132%
- X Month XXXXXXX +837%
- X Months XXXXXXX +88%
- X Year XXXXXXX +17%
Mentions: X #
- X Week XX no change
- X Month XX +3.50%
- X Months XXX +1.60%
- X Year XXX -XXXX%
Followers: XXXXXX #
- X Week XXXXXX +0.54%
- X Month XXXXXX +0.88%
- X Months XXXXXX +1.70%
- X Year XXXXXX +2.70%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence stocks XXXX% finance XXXX% technology brands XXXX%
Social topic influence novartis 1.43%, $googl XXXX%
Top accounts mentioned or mentioned by @jeff_cranmer @marketwirenews @sofinnovavcs @nvidia @usfdas @usfda @cincorpharma @albireopharma @wuxiapptec @wuxibiologics @seemacms @scottgottliebmd @pfizer @nociftw @biopharmajosh @cbtadvisors @flyingeagle86 @lcccc333 @fishburnsimone @akesoinc
Top assets mentioned Novartis AG (NVS) Alphabet Inc Class A (GOOGL)
Top Social Posts #
Top posts by engagements in the last XX hours
"Rare disease setbacks for Ultragenyx mid-stage win for Rhythm. Plus: Astrazeneca and Takeda preparing submissions after Phase III readouts in this weeks Clinical Report"
@BioCentury on X 2025-07-15 22:30:12 UTC 16.3K followers, XXX engagements
"Third patient dies from acute liver failure caused by a Sarepta gene therapy" @BioCentury on X 2025-07-18 00:00:08 UTC 16.3K followers, 93K engagements
"BioCentury's latest biopharma Management Moves: Steve Bates longtime head of BIA named executive chair of U.K.s Office of Life Sciences. Plus: Novartis names Mazuk chief patient experience officer and updates from Seres and ABPI" @BioCentury on X 2025-07-22 22:30:04 UTC 16.3K followers, XXX engagements
"BioCentury's latest in biopharma management moves: New leaders forJapan Bioindustry Association. Plus: Birgitte Stephensen retiring from Genmab as chief legal officer and updates from4D MolecularOruka andGenesis Research Group" @BioCentury on X 2025-07-03 01:30:09 UTC 16.3K followers, XXX engagements
"BioCentury's latest management tracks: Stumpe an alum of Tempus and Google named chief tech officer at Danaher. Plus: Updates from Cardiff Regenics X-chem" @BioCentury on X 2025-06-28 00:30:09 UTC 16.3K followers, XXX engagements